Navigation Links
Technology reveals 'lock and key' proteins behind diseases

ue. "Like lock and key, if two proteins interact with one another, it is safe to assume they participate or regulate the same cellular process," explains Stagljar. "Identifying new interactors for ABC transporters may reveal unanticipated aspects of how these transporters function and help researchers gain clues for fighting disease and drug resistance."

Using iMYTH, the Stagljar lab identified six proteins that interact with and presumably communicate with the ABC transporter Ycf1p, a yeast version of the human proteins CFTR and MRP. These newly discovered protein interactors represent novel potential pharmaceutical targets. Through a series of biochemical and genetic tests, the researchers discovered that one of these interactors, Tus1p, regulates Ycf1p transporter function in a completely novel way to stimulate its ability to remove toxins from the cell.

"The more we learn about membrane proteins, the better we can use this knowledge for pharmacological and clinical applications," Stagljar says. "We work by putting together biochemical processes piece by piece like a puzzle. Hopefully soon we will have a complete picture of how many other diseases such as breast cancer, heart diseases, arthritis and schizophrenia are caused by mutations in various human membrane proteins."
'"/>

Source:University of Toronto


Page: 1 2

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
3. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
4. Technology for monitoring fetal oxygen during labor offers no apparent benefit
5. Technology exists to keep E. coli out of food
6. A bacterial genome reveals new targets to combat infectious disease
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Examination of internal wiring of yeast, worm, and fly reveals conserved circuits
9. NYU study reveals how brains immune system fights viral encephalitis
10. Study reveals new technique for fingerprinting environmental samples
11. Study reveals dramatic difference between breast cancers in US and Africa

Post Your Comments:
(Date:11/3/2009)...h as 28 percent less likely to become pregnant and...h that earned a Michigan State University professo...ke, a researcher in the MSU College of Human Medic...roductive Biology, focused on data of nearly 50,00... Luke,s findings, which also can be applied to wo...
(Date:11/3/2009)...ool of Engineering and Applied Science have for th...oratory the enzyme responsible for producing the b... , The research, published Oct. 23 in the journ...pment of other compounds with similarly beneficial...e is one of the most interesting but least underst...
(Date:11/3/2009)...t Chicago have received $1 million from the Nation...lationship between "fat taxes" and food consumptio...he two-year project was made available through the..., The study will link state tax rates associated ...laden foods and beverages (soda, candy, baked good...
Breaking Biology News(10 mins):MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 1Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 2Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 3Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 1Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 1The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 3
.... 1, 2008 While hunting among chimpanzees is a gr... highly influential within the group. They are mor...r in their absence, according to a new study. The...imal Behaviour, shed light on how and why some ani...l variation among chimpanzees contributes to colle...
...vative computational approach could speed up the p...nt, researchers from the University of Chicago Med...tudy to be published in the February 2008 issue of...esearchers analyzed specific properties of the hum...arly a thousand FDA-approved drugs. They identifie...
...hers at the University of Southern California have...d the development of cancer in 90 percent of young...se. In the February 1 issue of Cancer Research, t...ith rising levels of PSA (prostate specific antige...ancer. , By early vaccination, we have basically...
Other Biology News:Key 'impact hunters' catalyze hunting among male chimpanzees 2Key 'impact hunters' catalyze hunting among male chimpanzees 3Study of successful drug targets could hasten development of new medications 2Study of successful drug targets could hasten development of new medications 3Prostate cancer: Watchful wait or vaccinate? 2Prostate cancer: Watchful wait or vaccinate? 3
(Date:11/6/2009)...v. 6 ,, 3Q09 Corpo...tenza(TM) E.U. Marketing Authorization to Astellas... commercial readiness activities Expanded managem...keting; and Director, Commercial Operations Appoi...Audit Committee chairman , Upcoming 2009 Mi...
(Date:11/6/2009)...he agenda for Arrowhead’s 2010 Personalized ...take place on February 22-24, 2010 in Philadelphia... we will highlight key issues in forming partnersh...periences. , Minneapolis,...owhead’s 2010 Personalized Medicine Partner...
(Date:11/5/2009).... 5 DSM Pharmaceutical Products to...iance with Galenix, Saint Jean D,Illac, France, wh...ufacturing partner for Galenix commercial products...laborate on business development opportunities co-...d on the strength of Galenix in drug product devel...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC B...ults for the quarter ended September 30, 2009. The...tables that follow. ,, Third Quarter 2009 ,...$0.01 per share for the third quarter of 2009 as c...re for the third quarter of 2008. ,, Net sales...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...es ViPS Member of Select Group of Companies, Perm... Work For CMS Over The N...Value to be Awarded under ESD, ELMWOOD PARK, N.J....PS subsidiary today announced that ViPS has,been s...e Centers for,Medicare and Medicaid Services (CMS)...
...L Consulting, a,business unit of PAREXEL Internati...iences consultancy serving the bio/pharmaceutical ...t it is strengthening its Good Manufacturing,Pract...l client base,address complexities of European Uni...regulations, quality, and safety. This initiative...
...ei Group Corporation,("Sosei"; TSE Mothers Index: ...ces that AD 337, an enantiomer of an approved, cen... a Phase II proof of principle trial,for the treat... multi-centre, randomised, double-blind, placebo,c...tigated the efficacy,safety and tolerability of AD...
Other Biology Technology:ViPS Awarded Enterprise Systems Development (ESD) Contract By CMS 2ViPS Awarded Enterprise Systems Development (ESD) Contract By CMS 3Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 2Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 3Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 4Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 5Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 6Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome 2
...ilZyme AP Conjugate Stabilizer is an aqueous solut...her non-toxic stabilizing chemicals in a MES buffe... This product contains a combination of 0.02% met...preservative. StabilZyme AP Conjugate Stabilizer ...
Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.
... nonspecific binding is a problem in your applicat...vidin products as superior alternatives to avidin ...derivative that combines several key features to p... low nonspecific binding properties. NeutrAvidin d...
BlueView Nucleic Acid Stain from Sigma-Aldrich
Biology Products: